Friday, November 15, 2024
Tag:

AI

Recursion Receives FDA Approval to Launch Phase 1 Trials for AI-Developed Cancer Treatment

Recursion Pharmaceuticals: A New Frontier in AI-Driven Drug Discovery In a groundbreaking announcement, Recursion Pharmaceuticals, a pioneer in the realm of artificial intelligence (AI) drug...